|

Ocrevus-US Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Ocrelizumab

Pipeline

Phase 3: 1

Top Sponsors

  • Sandoz1

Indications

  • Relapsing Multiple Sclerosis1
  • Multiple Sclerosis1

Maitland, Florida1 trial

Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

Sandoz Investigational Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.